Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
NILK-2301 by LamKap Bio Group for Solid Tumor: Likelihood of Approval
NILK-2301 is under clinical development by LamKap Bio Group and currently in Phase I for Solid Tumor. According to GlobalData,...
Data Insights
NILK-2301 by LamKap Bio Group for Metastatic Colorectal Cancer: Likelihood of Approval
NILK-2301 is under clinical development by LamKap Bio Group and currently in Phase I for Metastatic Colorectal Cancer. According to...